Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2019-01-03 19:21:20
Reporting Period:
Accepted Time:
2019-01-03 19:21:20
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538845 A Sean Power 2 Gansevoort St, 9Th Floor
New York NY 10011
Cfo, Secretary And Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-02 37,275 $4.13 400,992 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2018-12-31 115,000 $0.00 115,000 $4.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
115,000 2028-12-31 No 4 A Direct
  1. In connection with the vesting of 72,500 shares on January 1, 2019, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  2. Represents the weighted average sales price.
  3. Includes shares of restricted Common Stock, which are subject to vesting.
  4. The options vest according to the following schedule: 25% on each of January 1, 2020, January 1, 2021, January 1, 2022, and January 1, 2023.